Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články, systematický přehled
PubMed
34607722
PubMed Central
PMC8429356
DOI
10.1016/j.euroneuro.2021.09.001
PII: S0924-977X(21)00743-4
Knihovny.cz E-zdroje
- Klíčová slova
- Bipolar disorder, COVID-19, Infectious diseases, Systematic review, Vaccination,
- MeSH
- bipolární porucha * epidemiologie MeSH
- COVID-19 * MeSH
- infekční nemoci MeSH
- kontrola infekčních nemocí MeSH
- lidé MeSH
- pandemie MeSH
- SARS-CoV-2 MeSH
- vakcíny * aplikace a dávkování škodlivé účinky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- systematický přehled MeSH
- Názvy látek
- vakcíny * MeSH
Bipolar disorder (BD) might be associated with higher infection rates of coronavirus disease (COVID-19) which in turn could result in worsening the clinical course and outcome. This may be due to a high prevalence of somatic comorbidities and an increased risk of delays in and poorer treatment of somatic disease in patients with severe mental illness in general. Vaccination is the most important public health intervention to tackle the ongoing pandemic. We undertook a systematic review regarding the data on vaccinations in individuals with BD. Proportion of prevalence rates, efficacy and specific side effects of vaccinations and in individuals with BD were searched. Results show that only five studies have investigated vaccinations in individuals with BD, which substantially limits the interpretation of overall findings. Studies on antibody production after vaccinations in BD are very limited and results are inconsistent. Also, the evidence-based science on side effects of vaccinations in individuals with BD so far is poor.
BIOARABA Department of Neuroscience UPV EHU CIBERSAM Vitoria Spain
Department of Psychiatry University of Oxford Oxford United Kingdom
Dept of Psychiatry Amsterdam University Medical Centers Vrije Universiteit Amsterdam Netherlands
Dokuz Eylul University Izmir Turkey Department of Psychiatry
Institute of Neuroscience Newcastle University Newcastle UK
Medical University Graz Department of Psychiatry and Psychotherapeutic Medicine
Medical University Graz Klinische Abteilung für Rheumatologie und Immunologie
NORMENT Centre Division of Mental Health and Addiction Oslo University Hospital Oslo Norway
Zobrazit více v PubMed
Anderson G., Berk M., Dean O., Moylan S., Maes M. Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications. CNS Drugs. 2014;28(1):1–10. PubMed
Arbelo N., López-Pelayo H., Sagué M., Madero S., Pinzón-Espinosa J., Gomes-da-Costa S., Ilzarbe L., Anmella G., Llach C.D., Imaz M.L., Cámara M.M., Pintor L. Psychiatric Clinical Profiles and Pharmacological Interactions in COVID-19 Inpatients Referred to a Consultation Liaison Psychiatry Unit: a Cross-Sectional Study. Psychiatr. Q. 2021:1–13. PubMed PMC
Barber S., Reed L., Syam N., Jones N., 2020. Severe mental illness and risks from COVID-19, Available from: https://www.cebm.net/covid-19/severe-mental-illness-and-risks-from-covid19/#:∼:text=People%20with%20severe%20mental%20illness,data%20that%20quantified%20these%20risks.
Batty, G.D., Deary, I.J., Altschul, D., 2021. Pre-pandemic mental and physical health as predictors of COVID-19 vaccine hesitancy: evidence from a UK-wide cohort study. medRxiv [Preprint]. 2021 Apr 30:2021.04.27.21256185. doi:10.1101/2021.04.27.21256185. PubMed DOI PMC
Bazargan M., Wisseh C., Adinkrah E., Ameli H., Santana D., Cobb S., Assari S. Influenza Vaccination among Underserved African-American Older Adults. Biomed. Res. Int. 2020;2020(2):1–9. PubMed PMC
Breton G., Mendoza P., Hägglöf T., Oliveira T.Y., Schaefer-Babajew D., Gaebler C., Turroja M., Hurley A., Caskey M., Nussenzweig M.C. Persistent cellular immunity to SARS-CoV-2 infection. J. Exp. Med. 2021;218(4) PubMed PMC
Brodziński S., Nasierowski T. Psychosis in Borrelia burgdorferi infection–part II. Psychiatr. Pol. 2019;53(3):641–653. PubMed
Buchwald D., Sheffield J., Furman R., Hartman S., Dudden M., Manson S. Influenza and pneumococcal vaccination among Native American elders in a primary care practice. Arch. Intern. Med. 2000;160(10):1443–1448. PubMed
Castro M.V., Gunning F.M., McCoy T.H., Perlis R.H. Mood Disorders and outcomes of COVID-19 hospitalizations. Am. J. Psychiatry. 2021 doi: 10.1176/appi.ajp.2020.20060842. appiajp202020060842. PubMed DOI
Cohen S., Williamson G.M. Stress and infectious disease in humans. Psychol. Bull. 1991;109(1):5. PubMed
Colomer L., Anmella G., Vieta E., Grande I. Physical health in affective disorders: a narrative review of the literature. Braz. J. Psychiatry. 2020 S1516-44462020005037202. PubMed PMC
Correll C.U., Solmi M., Veronese N., Bortolato B., Rosson S., Santonastaso P., Thapa-Chhetri N., Fornaro M., Gallicchio D., Collantoni E., Pigato G., Favaro A., Monaco F., Kohler C., Vancampfort D., Ward P.B., Gaughran F., Carvalho A.F., Stubbs B. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16(2):163–180. PubMed PMC
Dalkner N., Reininghaus E., Schwalsberger K., Rieger A., Hamm C., Pilz R., Lenger M., Queissner R., Falzberger V.S., Platzer M., Fellendorf F.T., Birner A., Bengesser S.A., Weiss E.M., McIntyre R.S., Mangge H., Reininghaus B. C-Reactive Protein as a Possible Predictor of Trail-Making Performance in Individuals with Psychiatric Disorders. Nutrients. 2020;12(10):3019. PubMed PMC
De Beaurepaire R., Fattal-German M., Kramartz P., Gékière F., Bizzini B., Rioux P., Borenstein P. Etude des réactions immunitaires humorales et cellulaires dans diverses formes de pathologies psychiatriques 22 chroniques [Humoral and cellular immunologic reactions in various forms of chronic psychiatric diseases] Encephale. 1994;20(1):57–64. PubMed
De Hert M., Correll C.U., Bobes J., Cetkovich-Bakmas M., Cohen D.A.N., Asai I., Detraux J., Gautam S., Möller H.J., Ndetei D.M., Newcomer J.W., Uwakwe R., Leucht S. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World psychiatry. 2011;10(1):52. PubMed PMC
De Hert M., Dekker J.M., Wood D., Kahl K.G., Holt R.I.G., Möller H.J. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) Eur. Psychiatry. 2009;24(6):412–424. PubMed
De Hert M., Mazereel V., Detraux J., Van Assche K. Prioritizing COVID-19 vaccination for people with severe mental illness. World Psychiatry. 2020;2021:1. PubMed PMC
De Picker L.J., Dias M.C., Benros M.E., Vai B., Branchi I., Benedetti F., Borsini A., Leza J.C., Kärkkäinen H., Männikkö M., Pariante C.M., Güngör E.S., Szczegielniak A., Tamouza R., van der Markt A., Fusar-Poli P., Beezhold J., Leboyer M. Severe mental illness and European COVID-19 vaccination strategies. Lancet Psychiatry. 2021;8(5):356–359. PubMed PMC
De Serres G., Rouleau I., Skowronski D.M., Ouakki M., Lacroix K., Bédard F., Toth E., Landry M., Dupré N. Paresthesia and sensory disturbances associated with 2009 pandemic vaccine receipt: clinical features and risk factors. Vaccine. 2015;33(36):4464–4471. PubMed
Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Yolken R. Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder. J Affect Disord. 2013;150(2):456–459. PubMed
Ford B.N., Yolken R.H., Dickerson F.B., Teague T.K., Irwin M.R., Paulus M.P., Savitz J. Reduced immunity to measles in adults with major depressive disorder. Psychol. Med. 2019;49(2):243. PubMed PMC
Harris C., Barraclough B. Addressing mental health needs disorder. Br. J. Psychiatry. 1998;173(1):11–53. PubMed
Hayes J.F., Miles J., Walters K., King M., Osborn D.P.J. A systematic review and meta-analysis of premature mortality in bipolar affective disorder. Acta Psychiatr. Scand. 2015;131(6):417–425. PubMed PMC
Heggelund J., Vancampfort D., Tacchi M.J., Morken G., Scott J. Is there an association between cardiorespiratory fitness and stage of illness in psychotic disorders? A systematic review and meta-analysis. Acta Psychiatr. Scand. 2020;141(3):190–205. PubMed
Hernández-Gómez A., Andrade-González N., Lahera G., Vieta E. Recommendations for the care of patients with bipolar disorder during the COVID-19 pandemic. J. Affect. Disord. 2021;279:117–121. PubMed PMC
Kessing L.V., Ziersen S.C., Andersen P.K., Vinberg M.J.A. Nation-wide population-based longitudinal study mapping physical diseases in patients with bipolar disorder and their siblings. Affect Disord. 2021;282:18–25. PubMed
Kwon D.S., Kim K., Park S.M. Factors associated with influenza vaccination coverage among the elderly in South Korea: the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV) BMJ Open. 2016;6(12) e012618. 24. PubMed PMC
Lackner N., Mangge H., Reininghaus E.Z., McIntyre R.S., Bengesser S.A., Birner A., Reininghaus B., Kapfhammer H.P., Wallner-Liebmann S.J. Body fat distribution and associations with metabolic and clinical characteristics in bipolar individuals. Eur. Arch. Psychiatry Clin. Neurosci. 2015;265(4):313–319. PubMed
Landén M., Larsson H., Lichtenstein P., Westin J., Song J. Respiratory infections during lithium and valproate medication: a within-individual prospective study of 50,000 patients with bipolar disorder. Int. J. Bipolar Disord. 2021;9(1):4. PubMed PMC
Lavela S.L., Goldstein B., Etingen B., Miskevics S., Weaver F.M. Factors Associated With H1N1 influenza vaccine receipt in a high-risk population during the 2009-2010 H1N1 influenza pandemic. Top Spinal Cord. Inj. Rehabil. 2012;18(4):306–314. PubMed PMC
Lawrence T., Zubatsky M., Meyer D. The association between mental health diagnoses and influenza vaccine receipt among older primary care patients. Psychol. Health Med. 2020;25(9):1083–1093. PubMed
Lee S.W., Yang J.M., Moon S.Y., Yoo I.K., Ha E.K., Kim S.Y., Park U.M., Choi S., Lee S.-.H., Ahn Y.M., Kim J.M., Koh H.Y., Yon D.K. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study. Lancet Psychiatry. 2020;7(12):1025–1031. PubMed PMC
Leslie D.L., Kobre R.A., Richmand B.J., Aktan Guloksuz S., Leckman J.F. Temporal. Association of certain neuropsychiatric disorders following vaccination of children and adolescents: a pilot case-control study. Front. Psychiatry. 2017;8:3. PubMed PMC
Maripuu M., Bendix M., Öhlund L., Widerström M., Werneke U. Death Associated With Coronavirus (COVID-19) Infection in Individuals With Severe Mental Disorders in Sweden During the Early Months of the Outbreak-An Exploratory Cross-Sectional Analysis of a Population-Based Register Study. Front. Psychiatry. 2021;11 PubMed PMC
McIntyre R.S., Danilewitz M., Liauw S.S., Kemp D.E., Nguyen H.T., Kahn L.S., Kucyi A., Soczynska J.K., Woldeyohannes H.O., Lachowski A., Kim B., Nathanson J., Alsuwaidan M., Taylor V.H. Bipolar disorder and metabolic syndrome: an international perspective. J. Affect. Disord. 2010;126(3):366–387. PubMed
Miskovsky E., Gershman K., Clements M.L., Cupps T., Calandra G., Hesley T., Ioli V., Ellis R., Kniskern P., Miller W., Gerety R., West D. Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2+ S antigens. Vaccine. 1991;9(5):346–350. PubMed
Murali V., Oyebode F. Poverty, social inequality and mental health. Adv. Psychiatric Treatment. 2004;10(3):216–224.
Nielsen R.E., Banner J., Jensen S.E. Cardiovascular disease in patients with severe mental illness. Nat. Rev. Cardiol. 2021;18:136–145. PubMed
Patanavanich R., Glantz S.A. Smoking is associated with COVID-19 progression: a metaanalysis. Nicotine Tob. Res. 2020;22(9):1653–1656. PubMed PMC
Prather A.A., Pressman S.D., Miller G.E., Cohen S. Temporal Links Between Self-Reported Sleep and Antibody Responses to the Influenza Vaccine. Int. J. Behav. Med. 2021;28:151–158. PubMed
Queissner R., Pilz R., Dalkner N., Birner A., Bengesser S.A., Platzer M., Fellendorf F.T., Kainzbauer N., Herzog-Eberhard S., Hamm C., Reininghaus B., Zelzer S., Mangge H., Mansur R.B., McIntyre R.S., Kapfhammer H.P., Reininghaus E.Z. The relationship between inflammatory state and quantity of affective episodes in bipolar disorder. Psychoneuroendocrinology. 2018;90:61–67. PubMed
Rødevand L., Steen N.E., Elvsåshagen T., Quintana D.S., Reponen E.J., Mørch R.H., Lunding S.H., Vedal T.S.J., Dieset I., Melle I., Lagerberg T.V., Andreassen O.A. Cardiovascular risk remains high in schizophrenia with modest improvements in bipolar disorder during past decade. Acta Psychiatr. Scand. 2019;139(4):348–360. PubMed
Russo R., Ciminale M., Ditommaso S., Siliquini R., Zotti C., Ruggenini A.M. Hepatitis B vaccination in psychiatric patients. Lancet North Am. Ed. 1994;343(8893):356. PubMed
Seminog O.O., Goldacre M.J. Risk of pneumonia and pneumococcal disease in people with severe mental illness: english record linkage studies. Thorax. 2013;68(2):171–176. PubMed
Shinn A.K., Viron M. Perspectives on the COVID-19 pandemic and individuals with serious mental illness. J Clin Psychiatry. 2020;81(3) 20com13412. PubMed
Soresina A., Moratto D., Chiarini M., Paolillo C., Baresi G., Focà E., Bezzi M., Baronio B., Giacomelli M., Badolato R. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover. Pediatr. Allergy Immunol. 2020;31(5):565–569. PubMed PMC
Stefana A., Youngstrom E.A., Chen J., Hinshaw S., Maxwell V., Michalak E., Vieta E. The COVID-19 pandemic is a crisis and opportunity for bipolar disorder. Bipolar Disord. 2020;22(6):641–643. PubMed PMC
Taquet M., Luciano S., Geddes J.R., Harrison P.J. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8(2):130–140. PubMed PMC
Vancampfort D., Correll C.U., Galling B., Probst M., De Hert M., Ward P.B., Rosenbaum S., Gaughran F., Lally J., Stubbs B. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis. World Psychiatry. 2016;15(2):166–174. PubMed PMC
Vancampfort D., Stubbs B., Mitchell A.J., De Hert M., Wampers M., Ward P.B., Rosenbaum S., Correll C.U. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry. 2015;14(3):339–347. PubMed PMC
Vardavas C.I., Nikitara K. COVID-19 and smoking: a systematic review of the evidence. Tob. Induc. Dis. 2020;18:20. PubMed PMC
Wang J., Jiang M., Chen X., Montaner L.J. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J. Leukoc. Biol. 2020;108(1):17–41. PubMed PMC
Wang Q., Xu R., Volkow N.D. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry. 2021;20(1):124–130. PubMed PMC
Wasserman D., Iosue M., Wuestefeld A., Carli V. Adaptation of evidence-based suicide prevention strategies during and after the COVID-19 pandemic. World Psychiatry. 2020;19(3):294–306. PubMed PMC
Yamagata A.S., Rizzo L.B., Cerqueira R.O., Scott J., Cordeiro Q., McIntyre R.S., Mansur R.B., Brietzke E. Differential impact of obesity on CD69 expression in individuals with bipolar disorder and healthy controls. Mol. Neuropsychiatry. 2018;3(4):192–196. PubMed PMC
Yao H., Chen J.H., Xu Y.F. Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry. 2020;7(4):e21. PubMed PMC